Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy

PURPOSE: Previous cohort studies have reported plasma TK1 activity (pTKa) as a potential prognostic biomarker in estrogen receptor-positive (ER+) HER2-negative (HER2−) metastatic breast cancer (MBC). In this prospective study, we report here the prognostic impact of pTKa in ER+/HER2− MBC patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabel, Luc, Rosenblum, Dan, Lerebours, Florence, Brain, Etienne, Loirat, Delphine, Bergqvist, Mattias, Cottu, Paul, Donnadieu, Anne, Bethune, Anne, Kiavue, Nicolas, Rodrigues, Manuel, Pierga, Jean-Yves, Tanguy, Marie-Laure, Bidard, François-Clément
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489000/
https://www.ncbi.nlm.nih.gov/pubmed/32928264
http://dx.doi.org/10.1186/s13058-020-01334-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489000/
https://www.ncbi.nlm.nih.gov/pubmed/32928264
http://dx.doi.org/10.1186/s13058-020-01334-2

Ejemplares similares